ALEXIS J PILGRIM
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family JONESBORO, AR NPI 1316618309
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AR Medtronic, Inc. All categories
General Payments — all program years on this page
$3,086.81
- Category: General Payments
- Program years: PY2021–2024
- Record count: 125
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,091.94 across 38 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $769.04 | 34 |
| Education | $322.90 | 4 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $157.12 | 2 |
| Exelixis Inc. | $152.77 | 4 |
| Incyte Corporation | $99.95 | 1 |
| SANOFI-AVENTIS U.S. LLC | $98.00 | 1 |
| Merck Sharp & Dohme Corporation | $67.90 | 4 |
| Acerta Pharma LLC | $65.34 | 3 |
| Janssen Biotech, Inc. | $60.51 | 2 |
| Daiichi Sankyo Inc. | $54.55 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $52.46 | 3 |
| BeiGene USA, Inc. | $40.67 | 2 |
| GlaxoSmithKline, LLC. | $30.42 | 2 |
| GENZYME CORPORATION | $29.81 | 1 |
| ABBVIE INC. | $24.71 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.87 | 1 |
| Lilly USA, LLC | $20.64 | 1 |
| Stemline Therapeutics Inc. | $17.87 | 1 |
| PFIZER INC. | $17.54 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $17.03 | 1 |
| Dendreon Pharmaceuticals LLC | $16.98 | 1 |
| EISAI INC. | $16.38 | 1 |
| Ipsen Biopharmaceuticals, Inc | $14.81 | 1 |
| Pharmacosmos Therapeutics Inc. | $14.61 | 1 |
By program year
Records — PY2024 (38)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.